The impact of maternal body mass on the effectiveness of 17 alpha-hydroxyprogesterone caproate

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 53, Issue 9, 2008, Pages 667-671

  Ventolini, Gary ^a   Duke, Janice ^b   Po, William ^b   Barhan, Sheela ^b   Rhea, Debbie ^b   Desch, Cheryl ^b   Istwan, Niki ^b   Stanziano, Gary ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b NONE

Author keywords

17 hydroxy progesterone; Body mass index; Premature labor

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OBESITY; PREMATURE LABOR; PREPREGNANCY CARE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; HYDROXYPROGESTERONES; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; RECURRENCE; TOCOLYTIC AGENTS; YOUNG ADULT;

EID: 53549097629     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Martin JA, Hamilton BE, Sutton PD, et al: Births: Final data for 2004. National Vital Statistics Reports; vol. 55, no. 1. Hyattsville, MD, National Center for Health Statistics, 2006
2. Meis PJ, Klebanoff M, Thorn E, et al: Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-2385
3. da Fonseca EB, Bittar RE, Carvalho MH, et al: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double blind study. Am J Obstet Gynecol 2003;1884:419-424
4. Cnattingius S, Bergstrom R, Lipworth L, et al: Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998;338:147-152
5. Hendler I, Goldenberg RL, Mercer BM, et al: The Preterm Prediction Study: Association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol 2005;192:882-886
6. Meis PJ, Klebanoff M, Dombrowski MP, et al: Does progesterone treatment influence risk factors for recurrent preterm delivery? Obstet Gynecol 2005;106:557-561